MHTX Manhattan Scientifics Inc.

Manhattan Scientifics, Inc. focuses on technology transfer and commercialization of transformative technologies. The company operates as a technology incubator that seeks to acquire, develop and commercialize life-enhancing technologies in various fields. It also focuses on identifing emerging technologies through strategic alliances with scientific laboratories, educational institutions, scientists and leaders in industry and government. The company was founded by Marvin Maslow on July 31, 1992 and is headquartered in New York, NY.

This security is traded over-the-counter, or OTC. We don't always have accurate pricing data on OTC stocks.

$0.02    OTCQB
As of 01/24/2022     OTCMarkets

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Medical Devices
Index country:  USA
Country of incorporation:  
IPO date:  12/19/2001
Outstanding shares:  559,281,064
Average volume:  192,209
Market cap:   $8,389,216
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Valuation   (See tab for details)
PE ratio:   -3.25
PB ratio:   7.50
PS ratio:   167.78
Return on equity:   -79.33%
Net income %:   -1,696.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy